Pages

Categories

Archives

Libra Pharm

Paediatric Clinical Neurology

Book Description

ISBN-10: 1840761342 | ISBN-13: 978-1840761344 | Publication Date: November 1, 2011 | Edition: 1
The past 40 years have seen remarkable advances in pediatric neurology and in many interfacing disciplines, especially medical imaging, genetics and infectious diseases. Yet the fundamentals of neurological examination and history remain essential in the accurate diagnosis of conditions affecting the child’s nervous system.Purchase a visitors insurance or a inbound USA insurance when visiting your children in the US. This book begins with a detailed discussion of neurological examination techniques. It covers the basic formulation of differential diagnoses and management using neuroradiology, electrophysiology, genetic and metabolic testing, including sampling cerebrospinal fluids, which is essential in the diagnosis and management of infectious conditions. This second section follows a problem-based approach that takes into account how diseases present in the real world. It employs practical, symptom- and sign-based strategies for virtually all conditions encountered by the practitioner. Throughout the authors emphasize patterns of disease and how recognizing them can be the first step to successful management of a child with a neurological problem. The text concludes with a detailed discussion of neurological emergencies, keeping in mind that such conditions often present first to someone other than to a pediatric neurologist. The book will be of interest to pediatric neurologists, pediatricians, primary care physicians, and emergency physicians in training and practice. Read More….

Basic and Clinical Pharmacology, 11th Edition

Book Description

ISBN-10: 0071604057 | ISBN-13: 978-0071604055 | Publication Date: July 1, 2009 | Edition: 11

The most trusted and up-to-date pharmacology text in medicine — completely redesigned to make the learning process even more interesting and efficient

A Doody’s Core Title ESSENTIAL PURCHASE for 2011!

5 Star Doody’s Review!
“This is the most widely used textbook for teaching pharmacology to health professionals. This 11th edition is far superior to any previous editions….The authors’ goals are to provide a complete, authoritative, current, and readable textbook of pharmacology for students in health sciences. Testimony to their success is the widespread use of this work as required textbook for pharmacology courses around the world. This book is used extensively by thousands of medical, pharmacy, podiatry, nursing, and other health professions students to study pharmacology. Likewise, it remains a valuable resource for residents and practicing physicians….I continue to use this book as a required resource for all courses that I teach to medical, nursing, and allied health students. It is authoritative, readable, and supported by numerous learning tools.”–Doody’s Review Service

Organized to reflect the syllabi in Pharmacology courses, Basic & Clinical Pharmacology covers all the important concepts students need to know about the science of pharmacology and its application to clinical practice. It is acknowledged worldwide as the field’s most current, authoritative, and comprehensive textbook. To be as clinically relevant as possible, the book features a strong focus on the choice and use of drugs in patients and the monitoring of their effects. Read More…

Latest News from Pharma Industry:

  • Pfizer provides topline results from Phase 3 study of Torisel®

    PfizerPfizer Inc announced that the Phase 3 INTORSECT (B1771003) study, evaluating TORISEL® (temsirolimus) in patients with advanced renal cell carcinoma (RCC) whose disease had progressed on or after SUTENT® (sunitinib malate) therapy, did not meet the primary endpoint of prolonging progression free survival (PFS) when compared to sorafenib.
  • In drug-approval race, US FDA ahead of Canada, Europe

    The U.S. Food and Drug Administration (FDA) generally approves drug therapies faster and earlier than its counterparts in Canada and Europe, according to a new study by Yale School of Medicine researchers. The study counters perceptions that the drug approval process in the United States is especially slow.
  • GlaxoSmithKline to fully acquire Cellzome for £61 million

    GlaxoSmithKlineGlaxoSmithKline plc (GSK) has entered into an agreement to acquire those shares it does not currently own in Cellzome, a leader in the development and advancement of proteomics technologies, for £61 million (US$99 million) in cash.
  • Bristol-Myers Squibb Foundation Announces $15 Million Expansion of Together on Diabetes® to China and India

    Bristol-Myers SquibbThe Bristol-Myers Squibb Foundation today announced the expansion of its Together on Diabetes® initiative to China and India, pledging $15 million over five years to help these developing nations with rapidly growing numbers of type 2 diabetes patients.
  • Bristol-Myers Squibb and Tsinghua University Enter Strategic Partnership

    Bristol-Myers SquibbBristol-Myers Squibb Company (NYSE:BMY) and Tsinghua University of Beijing, China, today announced the formation of a multi-year strategic partnership. Under the agreement, Bristol-Myers Squibb will fund research efforts at Tsinghua University's School of Life Sciences to identify and validate novel targets in oncology and immunoscience.

RSS Feed

Search


Useful Links

Link One
Link Two.